Faecal calprotectin levels, C-reactive protein levels and partial Mayo score as early predictors of clinical and endoscopic outcomes in adult patients with moderately to severely active ulcerative colitis treated with tofacitinib in a Phase 2 study

Marla C. Dubinsky  1     David P. Hudesman  2     nicole kulisek  3     Leonardo Salese  3     Jerome Paulissen  4     Chinyu Su  3     Fernando Magro  5    
1 Icahn School of Medicine at Mount Sinai,New York, NY,United States
2 New York University,New York, NY,United States
3 Pfizer Inc,Collegeville, PA,United States
4 Syneos Health,Morrisville, NC,United States
5 University of Porto and Centro Hospitalar São

IBD I (Posters)

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing